Order Article Reprints

Kwiecińska-Piróg J, Przekwas J, Kraszewska Z, Sękowska A, Brodzka S, Wiktorczyk-Kapischke N, Grudlewska-Buda K, Wałecka-Zacharska E, Zacharski M, Mańkowska-Cyl A, et al. The Differences in the Level of Anti-SARS-CoV-2 Antibodies after mRNA Vaccine between Convalescent and Non-Previously Infected People Disappear after the Second Dose—Study in Healthcare Workers Group in Poland. Vaccines. 2021; 9(12):1402. https://doi.org/10.3390/vaccines9121402

Kwiecińska-Piróg, Joanna, Jana Przekwas, Zuzanna Kraszewska, Alicja Sękowska, Sylwia Brodzka, Natalia Wiktorczyk-Kapischke, Katarzyna Grudlewska-Buda, Ewa Wałecka-Zacharska, Maciej Zacharski, Aneta Mańkowska-Cyl, and et al. 2021. "The Differences in the Level of Anti-SARS-CoV-2 Antibodies after mRNA Vaccine between Convalescent and Non-Previously Infected People Disappear after the Second Dose—Study in Healthcare Workers Group in Poland" Vaccines 9, no. 12: 1402. https://doi.org/10.3390/vaccines9121402

Kwiecińska-Piróg, J., Przekwas, J., Kraszewska, Z., Sękowska, A., Brodzka, S., Wiktorczyk-Kapischke, N., Grudlewska-Buda, K., Wałecka-Zacharska, E., Zacharski, M., Mańkowska-Cyl, A., Gospodarek-Komkowska, E., & Skowron, K. (2021). The Differences in the Level of Anti-SARS-CoV-2 Antibodies after mRNA Vaccine between Convalescent and Non-Previously Infected People Disappear after the Second Dose—Study in Healthcare Workers Group in Poland. Vaccines, 9(12), 1402. https://doi.org/10.3390/vaccines9121402